Login / Register Order My Items
mob-logo
Contact Us
800.227.0627
Contact Us Quote Order Login / Register

Oligonucleotide PEGylation & Synthetic Polymer Conjugation

Custom oligonucleotide PEGylation and synthetic polymer conjugation for siRNA, ASO, PNA, and PMO — featuring site-specific 3′/5′/internal attachment with PEG, PAMAM, and advanced polymer systems.

Request a Quote Speak to a Chemist
Talk to a chemist Request a quote
Overview PAMAM Service categories Related services Deliverables & QC FAQ Recommended reading Contact

Overview

We provide custom oligonucleotide polymer conjugation services with a focus on high-intent use cases such as oligonucleotide PEGylation (including siRNA PEG conjugation and ASO PEGylation) and PAMAM dendrimer–oligonucleotide conjugation. Our workflows support defined attachment at the 3′ end, 5′ end, or internal positions to reduce heterogeneity and maintain hybridization performance.

Synthetic polymer conjugation is commonly used to tune solubility, steric shielding, hydrodynamic size, and formulation behavior. Polymer architecture and molecular weight (e.g., PEG 2–40 kDa or PAMAM G0–G10) are selected based on program objectives, installed functional handles, and the desired stability profile of the final linkage (cleavable vs non-cleavable).

We support PEG (linear/branched/discrete spacers), PEG alternatives (HPMA/POEGMA and related systems), biodegradable polyesters (PLGA/PCL), block copolymers, and stimuli-responsive designs. Fit-for-purpose analytics may include LC-MS for monodisperse systems, and SEC-HPLC/GPC for polymer distributions, along with purity profiling and degree-of-substitution (DOS) estimation.

All constructs are supplied for research and non-human use unless otherwise agreed in writing.

ISO 9001:2015 / ISO 13485:2016 45+ Years of Expertise U.S.A. Facilities-Texas GLP/GMP-Aligned

PAMAM Dendrimer–Oligonucleotide Conjugation

We routinely support PAMAM dendrimer–oligonucleotide conjugation for multivalent display and architecture-controlled constructs. PAMAM generations G0–G10 are supported on a project basis, with conjugation strategies designed to manage heterogeneity and deliver reproducible products.

Schematic of PAMAM dendrimer siRNA conjugation using NHS ester and maleimide crosslinking chemistry

Representative schematic of PAMAM dendrimer–siRNA conjugation using NHS–amine and maleimide–thiol coupling chemistry.

Primary use cases

  • Multivalent presentation of siRNA/ASO for screening concepts
  • Charge- and size-tuning via generation selection and substitution control
  • Modular coupling using orthogonal handles (amine/thiol/azide–alkyne)

Quality and analytics

  • Controlled degree of substitution (DOS) strategies
  • Removal of unconjugated oligonucleotide / scaffold where applicable
  • SEC-HPLC/GPC profiling for distribution; LC-MS when suitable

For PAMAM projects, we recommend defining acceptable DOS ranges early to support comparability across batches and scale-up.

Service Categories

Expand each category to view representative polymer classes, typical applications, and selection considerations. All examples are research/preclinical formats; feasibility is project-dependent.

PEGylation is one of the most established oligonucleotide–polymer conjugation strategies (including siRNA PEG conjugation and ASO PEGylation), commonly used to improve handling, tune hydrodynamic size, and provide controlled steric shielding.

Representative PEG formats Typical applications Notes
Linear PEG (2–40 kDa) Solubility enhancement; spacer/shielding Length selected to balance shielding with steric accessibility
Branched / multi-arm PEG Increased steric shielding; size modulation Higher apparent MW; architecture-dependent effects
Functional PEG (NHS, maleimide, azide/alkyne, DBCO) Site-defined conjugation workflows Supports amine/thiol coupling and click chemistry (SPAAC/CuAAC)

Cleavable and non-cleavable linkers are supported; chemistry selection depends on installed handles and desired linkage stability.

Biodegradable polymer–oligonucleotide conjugates are selected when polymer degradation or linker cleavage is part of the design concept.

Representative polymers Typical applications Notes
PLGA Degradation-enabled delivery concepts; formulation studies Composition-dependent degradation behavior
PCL Longer-duration degradation concepts Slower degradation; more hydrophobic
Other biodegradable polyesters Project-specific release concepts Selection guided by MW, architecture, and compatibility

Polymer MW/composition and oligonucleotide compatibility are evaluated early to reduce risk of aggregation or low recovery.

Hydrophilic synthetic polymers are explored as PEG alternatives to enhance solubility and tune surface properties or formulation behavior.

Representative polymers Typical applications Notes
HPMA Hydrophilic conjugates; handling improvement Well-studied polymer backbone
POEGMA PEG-mimetic “stealth” concepts PEG-like side chains; architecture-dependent behavior
Poly(acrylamide) derivatives Research-stage conjugates Architecture and MW tunable; analytics selected case-by-case

Selection is guided by oligonucleotide modality, target MW, and intended assay matrix.

Dendrimer–oligonucleotide conjugates enable multivalent display and controlled architectures for screening and delivery concepts.

Representative dendrimers Typical applications Notes
PAMAM (G0–G10) Multivalent oligonucleotide presentation High functional group density; DOS control recommended
Surface-modified PAMAM Charge-tuned concepts (project-dependent) Surface tailoring can reduce nonspecific binding risk

Higher-generation PAMAM formats are supported with generation-appropriate density control and analytics to reduce heterogeneity.

Stimuli-responsive designs can be implemented via the polymer backbone, pendant groups, or cleavable linkers to enable environment-triggered behavior.

Representative systems Typical applications Notes
pH-responsive systems Environment-triggered release concepts Often implemented via acid-labile linkers
Redox-cleavable systems Triggered release designs Commonly disulfide-based
Enzyme-cleavable linkers Microenvironment-responsive concepts Linker-driven responsiveness; project-defined triggers

Stability and trigger conditions are evaluated using project-defined buffers and test matrices.

Deliverables & Fit-for-Purpose QC

Supported attachment strategies

  • 5′ modification (common for polymer conjugation and handle installation)
  • 3′ modification (support-based installation or post-synthesis coupling)
  • Internal modification (base or backbone-linked handles; project-dependent)
  • Orthogonal handles (amine, thiol, azide/alkyne) for selective conjugation workflows

Defined site attachment is prioritized to reduce heterogeneity and preserve hybridization performance.

Representative analytical package

  • LC-MS (monodisperse systems; method-dependent)
  • SEC-HPLC / GPC (size distribution; polymer-dependent)
  • Degree of substitution (DOS) estimation
  • Chromatographic purity profiling and project-defined reporting

Analytics are tailored to polymer type, molecular weight, and intended application (discovery, delivery research, preclinical).

FAQ

What is oligonucleotide PEGylation?
Oligonucleotide PEGylation is the controlled covalent attachment of PEG to an oligonucleotide (e.g., siRNA or ASO) to improve handling, tune hydrodynamic size, and provide steric shielding. Attachment is commonly site-defined at the 3′ end, 5′ end, or internal positions. 3
When should I choose PEG vs PAMAM for oligonucleotide conjugation?
PEG is often selected for solubility, spacing, and predictable steric shielding (with PEG length as the primary tuning handle). PAMAM dendrimers are selected when multivalency or architecture-controlled constructs are desired; PAMAM generation (G0–G10) and DOS provide additional tuning. The best choice depends on application goals, conjugation site, and acceptable heterogeneity. 2
Do you support site-specific 3′/5′/internal polymer attachment?
Yes. Defined attachment at the 3′ end, 5′ end, or internal positions is supported using installed handles (amine, thiol, azide/alkyne) and orthogonal chemistries to reduce heterogeneity.
What analytics are available for polymer–oligo conjugates?
Fit-for-purpose characterization may include LC-MS (monodisperse systems), SEC-HPLC/GPC for size distribution, degree-of-substitution estimation, and chromatographic purity profiling. The final package is tailored to polymer class, molecular weight, and intended application. 3
Which conjugation chemistries are most common?
Common options include NHS–amine coupling, maleimide–thiol coupling, and click chemistry such as SPAAC (azide–DBCO) or CuAAC (azide–alkyne). Chemistry selection depends on installed handles, buffer compatibility, and the desired linkage stability (cleavable vs non-cleavable).
How do you control and report degree of substitution (DOS) for polymer–oligo conjugates?
For multivalent scaffolds (e.g., PAMAM) and functionalized polymers, we use project-defined targets for average loading and acceptable distributions, then confirm with fit-for-purpose analytical methods (e.g., SEC-HPLC/GPC, chromatographic purity profiling, and DOS estimation). Defining DOS acceptance criteria early improves comparability across batches and downstream screening decisions. 2 3
More FAQ'sAll FAQ's

Request a quote

What to provide

  • Oligonucleotide modality and sequence summary (siRNA/ASO/PNA/PMO; sense/antisense if applicable)
  • Preferred attachment site (3′ / 5′ / internal) and desired handle (amine, thiol, azide/alkyne)
  • Polymer class (PEG, PLGA, PCL, HPMA/POEGMA, block copolymer, PAMAM, or custom)
  • Polymer molecular weight / architecture (if known) and desired degree of substitution
  • Linker preference (cleavable vs non-cleavable) and intended application
  • Target quantity and fit-for-purpose QC expectations

Share your design details and timeline. Our scientists will recommend a feasible conjugation strategy and an analytical plan aligned to your project goals.

Fastest path

Request a Quote Contact Us

Recommended Reading

  • Review on overcoming delivery and cellular barriers for RNA therapeutics (context for conjugation-enabled delivery strategies). Nature Biotechnology (2017)
  • Review on advances in oligonucleotide drug delivery (design considerations for conjugates and delivery systems). Nature Reviews Drug Discovery (2020)
  • Review on nucleic acid chemical modification and conjugation concepts (handles and linkage stability considerations). Nature Reviews Chemistry (2019)
  • Review on stimuli-responsive polymers and emerging applications (pH/redox/enzyme-triggered systems relevant to polymer–oligo designs). ScienceDirect (2024)

Links are provided for reference; access may depend on institutional subscriptions.

Why Choose Bio-Synthesis

Trusted by biotech leaders worldwide for over 45+ years of delivering high quality, fast and scalable synthetic biology solutions.

Greetings Researchers,

Please be advised that any information, guidelines, writeups, and oral/video/graphic content on our website are intended solely as general guidelines.
It is the researcher's sole responsibility to conduct thorough research on the designs of the products intended for their experiments before submitting
their designs to Biosynthesis for review of production feasibility.
Thank you for your understanding.

Quick Links